Alzheimer’s drug

FDA approval of Alzheimer’s drug ‘rife with irregularities’ Three FDA advisers resigned in protest over Aduhelm’s approval. By Ben Whedon The Food and Drug Administration in 2021 granted approval to a controversial treatment for Alzheimer’s disease, […]